Comprehensive resources for cancer patients and caregivers can be found on Patient Resource’s website. This is valuable information, not only for GIST patients, but also for those who may have friends and loved ones with other diagnoses.
A new cancer classification system that supports the idea of personalized medicine has been found as a result of a research study by University of California, San Francisco, indicated that more accurate diagnoses could be made based on genetic makeup.
Dialogue with your treatment team about your prognosis is key in maintaining open lines of communication. Ira Byock, MD shares some tips for talking about prognosis with your physician.
All relationships have to weather storms, but when a couple faces the challenges of cancer treatment, intimacy can suffer. Intimacy can be difficult for any couple, but cancer and intimacy can be an even larger obstacle.
A recent study from the Annals of Surgical Oncology (August, 2014) analyzes data found in the GIST registry conducted by the Kinki GIST Study Group in Japan. It was determined that by identifying asymptomatic patients, the Japanese gastric cancer screening system contributed to early detection of gastric GIST and favorable treatment outcomes.
The Life Raft Group, in partnership with the National Institutes of Health, is pleased to announce that applications are currently being accepted for the second meeting of the NIH-LRG Virtual GIST Tumor Board.
A recent article in Woman’s Day provides valuable insight into how to reach out to someone when you learn they have been diagnosed with cancer. Here's a list of ten things you should never say to a cancer patient.
The European Commission recently announced that Stivarga (regorafenib) from Bayer has been approved in the European Union (EU) as a third line treatment for GIST.
As wonderful as the sun feels, especially after the harsh winter many of us experienced, its effects are cause for concern, especially for patients already challenged with skin issues. Keep reading to learn some skin protection tips for GIST patients.
Lancet Oncology, a comprehensive overview of known or suspected drug-drug interactions between tyrosine-kinase inhibitors (Gleevec, Sutent, Stivarga) prescribed for GIST.